James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

MSFT’s True Cloud Potential Makes Microsoft Stock a Worthy Buy

Don't look now, but MSFT is becoming a fierce competitor in the cloud arena, despite the complaints from the biggest owner of Microsoft stock.

Why Pandora Media Inc (P), Principal Financial Group Inc (PFG) and Yahoo! Inc. (YHOO) Are 3 of Today’s Worst Stocks

Pandora Media (P), Principal Financial Group (PFG) and Yahoo! (YHOO) dished out more than their fair share of misery on Thursday. Here's what investors need to know.

Another Bad Quarter From Sears Sends SHLD Lower … Again

Sears Holdings is not going gently into the night, but don't mistake stubbornness for strength -- SHLD is on its deathbed

Should You Buy Merck Stock? 3 Pros, 3 Cons (MRK)

Merck (MRK) hasn't had a great 2015, but 2016 should serve up more of a tailwind than a headwind for owners of Merck stock.

Kinder Morgan Inc – So Bad It’s Finally Good? (KMI)

After an outright drubbing this year, Kinder Morgan (KMI) stock could a great buying opportunity that nobody is talking about.